| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Director | Chief Business Officer +1 more
3 companies
Henderson Michael Thomas is a Chief Executive Officer at APGE, with reported holdings spanning 3 companies. Recent filings cover 1 purchase and 76 sales. Those positions are worth an estimated $21.2M at current prices.
Our model assigns Henderson Michael Thomas a middling insider score of 57/100, based on 14 past trades. Over a 12-month horizon, 44.4% of those trades were profitable, with an average 12-month return of -20.8%.
Henderson Michael Thomas's largest disclosed position is in BBIO as Chief Business Officer, worth about $14.4M. The recent filings there lean toward selling, a net 96,850 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 8, 2026 | APGE Apogee Therapeutics, Inc. | Chief Executive Officer | Sell | 20,000 | $133.63 | $2,672,600.00 | -2.0% | - | - | |
| Jun 22, 2026 | APGE Apogee Therapeutics, Inc. | Chief Executive Officer | Sell | 80,000 | $132.54 | $10,603,200.00 | -7.3% | - | - | |
| Jun 22, 2026 | SYRE Spyre Therapeutics, Inc. | Director | Sell | 20,000 | $100.00 | $2,000,000.00 | -22.6% | -8.3% | - | |
| May 8, 2026 | SYRE Spyre Therapeutics, Inc. | Director | Sell | 80,000 | $74.40 | $5,952,050.43 | -47.4% | +37.8% | - | |
| Apr 8, 2026 | APGE Apogee Therapeutics, Inc. | Chief Executive Officer | Sell | 20,000 | $82.58 | $1,651,664.00 | -1.7% | +60.7% | - | |
| Jan 14, 2026 | APGE Apogee Therapeutics, Inc. | Chief Executive Officer | Sell | 20,000 | $81.11 | $1,622,159.12 | -1.6% | +7.3% | - | |
| Dec 10, 2025 | APGE Apogee Therapeutics, Inc. | Chief Executive Officer | Sell | 20,000 | $75.38 | $1,507,656.55 | -1.6% | -0.9% | - | |
| Dec 4, 2025 | APGE Apogee Therapeutics, Inc. | Chief Executive Officer | Sell | 40,000 | $75.01 | $3,000,400.00 | -3.1% | -4.3% | - | |
| Nov 13, 2025 | APGE Apogee Therapeutics, Inc. | Chief Executive Officer | Sell | 20,000 | $63.01 | $1,260,236.10 | -1.5% | +4.5% | - | |
| Mar 5, 2025 | APGE Apogee Therapeutics, Inc. | Chief Executive Officer | Sell | 10,000 | $30.15 | $301,511.36 | -0.8% | +18.0% | +125.8% |